Biofrontera Inc. Form 8-K Summary
Business Context and Reporting Period
Biofrontera Inc. filed a Form 8-K reporting the results of its Annual Meeting of Stockholders held on December 20, 2023. The filing was signed on December 27, 2023. The company is incorporated in Delaware and its common stock and warrants trade on Nasdaq under BFRI and BFRIW, respectively.
Financial and Operating Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating performance metrics. It is limited to matters submitted to stockholders for a vote.
Material Changes Versus the Prior Comparable Period
The filing text does not report material financial or operating changes versus a prior comparable period.
Annual Meeting Results, Outlook, and Risks
- Of 1,517,628 outstanding shares entitled to vote, 883,767 shares were represented in person or by proxy, constituting 58.2% and establishing a quorum.
- Beth J. Hoffman, Ph.D., was elected as a Class II director for a term expiring at the 2026 annual meeting or until her earlier death, resignation, or removal. The vote was 531,471 for, 9,810 withheld, and 342,486 broker non-votes.
- Kevin D. Weber was elected as a Class II director for a term expiring at the 2026 annual meeting or until his earlier death, resignation, or removal. The vote was 531,796 for, 9,485 withheld, and 342,486 broker non-votes.
- Stockholders ratified the appointment of Marcum LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023. The vote was 878,777 for, 2,734 against, and 2,256 abstentions; broker non-votes were not applicable.
- No other matters were considered or voted on. The filing contains no guidance, management outlook, contingencies, or unusual financial items.
Key Facts for Investor Verification
- Confirm the director election terms and final vote counts.
- Confirm stockholder approval of Marcum LLP for fiscal year 2023.
- Review the November 17, 2023 proxy statement for detailed proposal information.
- Obtain the company’s applicable periodic financial filing for revenue, profitability, cash flow, debt, liquidity, and risk disclosures, which are not included in this Form 8-K.